(MedPage Today) — Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector cell-associated enterocolitis (IEC-EC), the FDA announced on Friday.
Trials and postmarketing adverse event data…
Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/117914
Author :
Publish date : 2025-10-13 15:43:00
Copyright for syndicated content belongs to the linked Source.
